Clinical impact of lymphatic spread in patients with limited-stage upper aerodigestive tract NK/T cell lymphoma

다국어 초록 (Multilingual Abstract)

Background We investigated whether distancemax, that is, the degree of distance between the upper aerodigestive tract (UAT) mass and the farthest pathologic lymph node, was significantly associated with survival in patients with limited-stage UAT natural killer/T cell lymphoma (NKTCL).
Methods A total of 157 patients who received chemotherapy (CTx) with/without radiotherapy (RTx) were enrolled.
Results In the survival analysis, an elevated lactate dehydrogenase level [progression-free survival (PFS): hazard ratio (HR), 2.948; 95% confidence interval (CI), 1.606‒5.404; P ＜0.001; overall survival (OS): HR, 2.619; 95% CI, 1.594‒4.822; P =0.003], short distancemax (PFS: HR, 0.170; 95% CI, 0.071‒0.410; P ＜0.001; OS: HR, 0.142; 95% CI, 0.050‒0.402; P ＜ 0.001), and CTx combined with RTx (HR, 0.168; 95%CI, 0.079‒0.380; P ＜0.001; OS: HR, 0.193; 95% CI, 0.087‒0.429; P ＜0.001) had an independent predictive value for PFS and OS.
Conclusion The evaluation of the degree of lymphatic spread and local control by CTx combined with RTx is essential in patients with limited-stage UAT NKTCL.

참고문헌 (Reference)

1 Li YX, "Variable clinical presentations of nasal and Waldeyer ring natural killer/T-cell lymphoma" 15 : 2905-2912, 2009

2 Li CC, "Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer/T-cell or T-cell lymphoma" 100 : 366-375, 2004

3 Cheson BD, "Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group" 17 : 1244-, 1999

4 You JY, "Radiation therapy versus chemotherapy as initial treatment for localized nasal natural killer(NK)/T-cell lymphoma : a single institute survey in Taiwan" 15 : 618-625, 2004

5 Suzuki R, "Prognostic factors for mature natural killer(NK)cell neoplasms : aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type" 21 : 1032-1040, 2010

6 Cheung MM, "Primary non-Hodgkin’s lymphoma of the nose and nasopharynx : clinical features, tumor immunophenotype, and treatment outcome in 113 patients" 16 : 70-77, 1998

7 Chim CS, "Primary nasal natural killer cell lymphoma : long-term treatment outcome and relationship with the International Prognostic Index" 103 : 216-221, 2004

8 Robbins KT, "Primary lymphomas of the nasal cavity and paranasal sinuses" 56 : 814-819, 1985

9 Chan JY, "Novel findings from the Asian Lymphoma Study Group : focus on T and NK-cell lymphomas" 107 : 413-419, 2018

10 Ko YH, "NK and NK-like T-cell lymphoma in extranasal sites : a comparative clinicopathological study according to site and EBV status" 44 : 480-489, 2004

11 Logsdon MD, "Lymphoma of the nasal cavity and paranasal sinuses : improved outcome and altered prognostic factors with combined modality therapy" 80 : 477-488, 1997

12 Kim TM, "Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage I(E)/II(E)extranodal NK/T-cell lymphoma, nasal type" 106 : 3785-3790, 2005

13 Lee J, "Extranodal natural killer T-cell lymphoma, nasal-type : a prognostic model from a retrospective multicenter study" 24 : 612-618, 2006

14 Lee J, "Extranodal nasal type NK/T-cell lymphoma : elucidating clinical prognostic factors for risk-based stratification of therapy" 41 : 1402-1408, 2005

15 Cheung MM, "Early stage nasal NK/T-cell lymphoma : clinical outcome, prognostic factors, and the effect of treatment modality" 54 : 182-190, 2002

16 Kim TM, "Clinical heterogeneity of extranodal NK/T-cell lymphoma, nasal type : a national survey of the Korean Cancer Study Group" 19 : 1477-1484, 2008

17 Kim K, "Clinical features of peripheral T-cell lymphomas in 78 patients diagnosed according to the Revised European-American lymphoma(REAL)classification" 38 : 75-81, 2002

18 Li YX, "Clinical features and treatment outcome of nasal-type NK/T-cell lymphoma of Waldeyer ring" 112 : 3057-3064, 2008

19 Jo JC, "Clinical features and prognostic model for extranasal NK/T-cell lymphoma" 89 : 103-110, 2012

20 Au WY, "Clinical differences between nasal and extranasal natural killer/T-cell lymphoma : a study of 136 cases from the International Peripheral T-Cell Lymphoma Project" 113 : 3931-3937, 2009

21 Avilés A, "Angiocentric nasal T/natural killer cell lymphoma : a single centre study of prognostic factors in 108 patients" 22 : 215-220, 2000

22 Kim SJ, "A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment : a multicentre, retrospective analysis" 17 : 389-400, 2016

23 Yan Z, "A TNM staging system for nasal NK/T-cell lymphoma" 10 : e0130984-, 2015